Overview of ECMO Modalities and Indications

Extracorporeal membrane oxygenation provides temporary support for severe respiratory or cardiac failure by circulating blood through an external oxygenator and returning oxygenated blood to the patient and common configurations include venovenous ECMO for isolated respiratory failure and venoarterial ECMO for combined cardiac and respiratory support. Indications include refractory hypoxemia severe hypercapnia and reversible cardiac failure when conventional therapies fail and patient selection considers underlying disease reversibility comorbidities and potential for recovery. ECMO is resource intensive and requires multidisciplinary teams with expertise in cannulation anticoagulation and in management of complex physiology and complications.

Cannulation Circuits and Anticoagulation

ECMO circuits include cannulas pump oxygenator and heat exchanger and cannulation strategies vary with patient size and clinical goals and require imaging guided placement and surgical or percutaneous expertise. Anticoagulation prevents circuit thrombosis and is balanced against bleeding risk with frequent monitoring of coagulation parameters and adjustment of anticoagulant dosing. Circuit surveillance includes monitoring for hemolysis oxygenator performance and for pressure changes that indicate clot formation and prompt exchange when necessary. Clear protocols for emergency management of circuit failure and for safe transport of patients on ECMO are essential for program safety.

Patient Management and Complications

Management of patients on ECMO includes optimization of ventilator settings to minimize lung injury management of fluid balance and of nutrition and prevention of infection and of bleeding. Complications include bleeding thromboembolism hemolysis and infection and require proactive surveillance and multidisciplinary interventions. Weaning from ECMO involves assessment of native lung or cardiac recovery through trial reductions in support and through imaging and gas exchange testing and successful decannulation follows demonstration of sustained physiologic stability. ECMO programs maintain rigorous training simulation and quality assurance to ensure safe delivery of this advanced therapy.